Quantum Pharmaceuticals

Quantum Pharmaceuticals was a pioneering computational drug discovery company that utilized a proprietary physics-based platform to accelerate the development of novel small molecule therapeutics. The company's core technology, the Quantum Discovery platform, integrated quantum mechanics and molecular dynamics to simulate molecular interactions and predict binding affinities with high precision, aiming to identify high-affinity leads for challenging biological targets. Their internal pipeline historically focused on infectious diseases, including HIV and influenza, as well as various oncology indications. While the company was an early leader in the application of theoretical physics to drug design, its operations have largely ceased, with the founding team transitioning to focus on AI-driven longevity research at Gero.